XNC-59195-45462
4 vaccinations
4 coded responses
26 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 028 / RI
- Registered
- 2021-03-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Dose 2 — Pfizer-BioNTech
-
2021-03-28
Registered in v-safe
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-08
-
2021-04-15
Survey response — day 21, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Oligomenorrhoea — Feeling: GoodFree text: Heavier than normal menstruation during my period, longer period (4 days rather than my usual 3), worse cramping with my period.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — day 28, dose 2MedDRA: Headache — Feeling: GoodFree text: Worse headaches than usualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-29
- 2021-05-06
- 2021-06-24
-
2021-09-23
Survey response — 6 months, dose 2MedDRA: Hyperemesis gravidarum — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: PregnancyHyperemesis gravidarumMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2021-09-27
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-11-04
Dose 3 — Pfizer-BioNTech
- 2022-03-25
-
2022-10-13
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-10-15
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-10-16
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessFree text: Swollen/painful axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
- 2022-10-17
- 2022-10-18
- 2022-10-19
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-12
- 2022-11-17
- 2022-11-24
- 2023-01-12
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | |
| 2 | 2021-03-25 | Pfizer-BioNTech | |
| 3 | 2021-11-04 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-23 | Successful 2021-09-27 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — day 21, dose 2
Symptoms: Heavier than normal menstruation during my period, longer period (4 days rather than my usual 3), worse cramping with my period.
Release 7 — day 28, dose 2
Symptoms: Worse headaches than usual
Release 9 — 6 months, dose 2
Symptoms: PregnancyHyperemesis gravidarum
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Swollen/painful axillary lymph nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hyperemesis gravidarum | · | · | ✓ |
| SD | Oligomenorrhoea | ✓ | ✓ | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release